241 — Alibaba Health Information Technology Income Statement
0.000.00%
Last trade - 00:00- HK$44.39bn
- HK$34.12bn
- CNY27.03bn
- 81
- 25
- 42
- 46
Annual income statement for Alibaba Health Information Technology, fiscal year end - March 31st, CNY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | HKAS | HKAS | HKAS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 9,596 | 15,518 | 20,578 | 26,763 | 27,027 |
| Cost of Revenue | |||||
| Gross Profit | 2,231 | 3,617 | 4,108 | 5,701 | 5,895 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 9,531 | 15,076 | 20,781 | 26,218 | 26,075 |
| Operating Profit | 65.1 | 442 | -203 | 545 | 951 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 9.09 | 401 | -253 | 551 | 939 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -15.7 | 343 | -266 | 537 | 883 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.59 | 349 | -266 | 536 | 883 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.59 | 349 | -266 | 536 | 883 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.004 | 0.021 | -0.038 | 0.035 | 0.058 |